Feng Xu

机构：Shandong University of Technology, Ningbo Medical Center Lihuili Hospital, First Hospital of China Medical University, China Academy of Chinese Medical Sciences, Affiliated Hospital of Jining Medical University, Jinzhou Medical University, China Medical University · ORCID：0000-0001-7638-6526

发表论文 75 篇 · 总被引 1530 次 · h-index 21

代表论文

• Endothelial cell-derived exosomes trigger a positive feedback loop in osteogenesis-angiogenesis coupling via up-regulating zinc finger and BTB domain containing 16 in bone marrow mesenchymal stem cell (2024 · Journal of Nanobiotechnology · 被引 35)
• Circ-FOXM1 knockdown suppresses non-small cell lung cancer development by regulating the miR-149-5p/ATG5 axis (2021 · Cell Cycle · 被引 27)
• Using transcriptomics, proteomics and phosphoproteomics as new approach methodology (NAM) to define biological responses for chemical safety assessment (2022 · Chemosphere · 被引 26)
• PDGFR-β+ fibroblasts deteriorate survival in human solid tumors: a meta-analysis (2021 · Aging · 被引 14)
• Baicalein ameliorates oxidative stress and brain injury after intracerebral hemorrhage by activating the Nrf2/ARE pathway via miR-106a-5p/PHLPP2 axis (2022 · International Journal of Neuroscience · 被引 13)
• A case of intrathyroid thymic carcinoma (2023 · Asian Journal of Surgery · 被引 10)